BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.360
+0.050 (3.82%)
Mar 26, 2026, 4:00 PM EDT - Market closed
BioVie Market Cap
BioVie has a market cap or net worth of $10.26 million as of March 27, 2026. Its market cap has decreased by -46.84% in one year.
Market Cap
10.26M
Enterprise Value
-9.97M
1-Year Change
-46.84%
Ranking
Category
Stock Price
$1.36
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $10.26M, a decrease of -80.27%. That is a compound annual growth rate of -25.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 9.90M | 13.79% |
| Dec 31, 2025 | 8.70M | -75.49% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoMed Therapeutics | 11.89M |
| Moleculin Biotech | 11.21M |
| NewcelX | 11.17M |
| CalciMedica | 10.18M |
| BioLineRx | 10.10M |
| BioAtla | 9.99M |
| Lunai Bioworks | 9.93M |
| Theriva Biologics | 9.64M |